NCT03248856View on ClinicalTrials.gov

Triamcinolone Levels in Cochlear Perilymph

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 2, 2017

Primary Completion Date

December 31, 2020

Study Completion Date

May 31, 2021

Conditions
Cochlear Hearing Loss
Interventions
DRUG

Triamcinolone Acetonide

Intratympanic administration

Trial Locations (1)

1090

Medical University of Vienna (AKH), Vienna

All Listed Sponsors
lead

Christoph Arnoldner

OTHER

NCT03248856 - Triamcinolone Levels in Cochlear Perilymph | Biotech Hunter | Biotech Hunter